ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization

α-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. H...

Descripción completa

Detalles Bibliográficos
Autores: Peña Díaz, Samuel|||0000-0002-2902-823X, Pujols Pujol, Jordi|||0000-0001-9424-5866, Conde Giménez, María|||0000-0003-4358-9110, Carija, Anita|||0000-0001-5972-7448, Dalfo, Esther|||0000-0003-4677-8515, García, Jesús, Navarro, Susanna|||0000-0001-8160-9536, Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528, Santos Suárez, Jaime|||0000-0001-9045-7765, Salvatella, Xavier|||0000-0002-8371-4185, Sancho Sanz, Javier|||0000-0002-2879-9200, Ventura, Salvador|||0000-0002-9652-6351
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:223739
Acceso en línea:https://ddd.uab.cat/record/223739
https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306
Access Level:acceso abierto
Palabra clave:Parkinson's disease
α-synuclein
Amyloid
Protein aggregation
Aggregation inhibitor
Caenorhabditis elegans
Neurodegeneration
id ES_b4eae9d1fbab390c505e52604fff08cd
oai_identifier_str oai:ddd.uab.cat:223739
network_acronym_str ES
network_name_str España
repository_id_str
spelling ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerizationPeña Díaz, Samuel|||0000-0002-2902-823XPujols Pujol, Jordi|||0000-0001-9424-5866Conde Giménez, María|||0000-0003-4358-9110Carija, Anita|||0000-0001-5972-7448Dalfo, Esther|||0000-0003-4677-8515García, JesúsNavarro, Susanna|||0000-0001-8160-9536Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528Santos Suárez, Jaime|||0000-0001-9045-7765Salvatella, Xavier|||0000-0002-8371-4185Sancho Sanz, Javier|||0000-0002-2879-9200Ventura, Salvador|||0000-0002-9652-6351Parkinson's diseaseα-synucleinAmyloidProtein aggregationAggregation inhibitorCaenorhabditis elegansNeurodegenerationα-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. Here, we describe the capacity of a small molecule (ZPD-2), identified after a high-throughput screening, to inhibit α-Syn aggregation. ZPD-2 inhibits the aggregation of wild-type α-Syn and the A30P and H50Q familial variants in vitro at substoichiometric compound:protein ratios. In addition, the molecule prevents the spreading of α-Syn seeds in protein misfolding cyclic amplification assays. ZPD-2 is active against different α-Syn strains and blocks their seeded polymerization. Treating with ZPD-2 two different PD Caenorhabditis elegans models that express α-Syn either in muscle or in dopaminergic (DA) neurons substantially reduces the number of α-Syn inclusions and decreases synuclein-induced DA neurons degeneration. Overall, ZPD-2 is a hit compound worth to be explored in order to develop lead molecules for therapeutic intervention in PD. 22019-01-0120192019-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/223739https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengEuropean Commission https://doi.org/10.13039/501100000780 648201Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BIO2015-70092-RAgencia Estatal de Investigación https://doi.org/10.13039/501100011033 BIO2016-78310-RMinisterio de Economía y Competitividad https://doi.org/10.13039/501100003329 BFU2016-78232-Popen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2237392026-06-06T12:50:31Z
dc.title.none.fl_str_mv ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
title ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
spellingShingle ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
Peña Díaz, Samuel|||0000-0002-2902-823X
Parkinson's disease
α-synuclein
Amyloid
Protein aggregation
Aggregation inhibitor
Caenorhabditis elegans
Neurodegeneration
title_short ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
title_full ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
title_fullStr ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
title_full_unstemmed ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
title_sort ZPD-2, a small compound that inhibits α-synuclein amyloid aggregation and its seeded polymerization
dc.creator.none.fl_str_mv Peña Díaz, Samuel|||0000-0002-2902-823X
Pujols Pujol, Jordi|||0000-0001-9424-5866
Conde Giménez, María|||0000-0003-4358-9110
Carija, Anita|||0000-0001-5972-7448
Dalfo, Esther|||0000-0003-4677-8515
García, Jesús
Navarro, Susanna|||0000-0001-8160-9536
Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
Santos Suárez, Jaime|||0000-0001-9045-7765
Salvatella, Xavier|||0000-0002-8371-4185
Sancho Sanz, Javier|||0000-0002-2879-9200
Ventura, Salvador|||0000-0002-9652-6351
author Peña Díaz, Samuel|||0000-0002-2902-823X
author_facet Peña Díaz, Samuel|||0000-0002-2902-823X
Pujols Pujol, Jordi|||0000-0001-9424-5866
Conde Giménez, María|||0000-0003-4358-9110
Carija, Anita|||0000-0001-5972-7448
Dalfo, Esther|||0000-0003-4677-8515
García, Jesús
Navarro, Susanna|||0000-0001-8160-9536
Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
Santos Suárez, Jaime|||0000-0001-9045-7765
Salvatella, Xavier|||0000-0002-8371-4185
Sancho Sanz, Javier|||0000-0002-2879-9200
Ventura, Salvador|||0000-0002-9652-6351
author_role author
author2 Pujols Pujol, Jordi|||0000-0001-9424-5866
Conde Giménez, María|||0000-0003-4358-9110
Carija, Anita|||0000-0001-5972-7448
Dalfo, Esther|||0000-0003-4677-8515
García, Jesús
Navarro, Susanna|||0000-0001-8160-9536
Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
Santos Suárez, Jaime|||0000-0001-9045-7765
Salvatella, Xavier|||0000-0002-8371-4185
Sancho Sanz, Javier|||0000-0002-2879-9200
Ventura, Salvador|||0000-0002-9652-6351
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Parkinson's disease
α-synuclein
Amyloid
Protein aggregation
Aggregation inhibitor
Caenorhabditis elegans
Neurodegeneration
topic Parkinson's disease
α-synuclein
Amyloid
Protein aggregation
Aggregation inhibitor
Caenorhabditis elegans
Neurodegeneration
description α-Synuclein (α-Syn) forms toxic intracellular protein inclusions and transmissible amyloid structures in Parkinson's disease (PD). Preventing α-Syn self-assembly has become one of the most promising approaches in the search for disease-modifying treatments for this neurodegenerative disorder. Here, we describe the capacity of a small molecule (ZPD-2), identified after a high-throughput screening, to inhibit α-Syn aggregation. ZPD-2 inhibits the aggregation of wild-type α-Syn and the A30P and H50Q familial variants in vitro at substoichiometric compound:protein ratios. In addition, the molecule prevents the spreading of α-Syn seeds in protein misfolding cyclic amplification assays. ZPD-2 is active against different α-Syn strains and blocks their seeded polymerization. Treating with ZPD-2 two different PD Caenorhabditis elegans models that express α-Syn either in muscle or in dopaminergic (DA) neurons substantially reduces the number of α-Syn inclusions and decreases synuclein-induced DA neurons degeneration. Overall, ZPD-2 is a hit compound worth to be explored in order to develop lead molecules for therapeutic intervention in PD.
publishDate 2019
dc.date.none.fl_str_mv 2
2019-01-01
2019
2019-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/223739
https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306
url https://ddd.uab.cat/record/223739
https://dx.doi.org/urn:doi:10.3389/fnmol.2019.00306
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv European Commission https://doi.org/10.13039/501100000780 648201
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BIO2015-70092-R
Agencia Estatal de Investigación https://doi.org/10.13039/501100011033 BIO2016-78310-R
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 BFU2016-78232-P
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417299694321664
score 15,300724